When post treatment serum PSA (prostate-specific antigen) levels rise, the patient is treated by first-line androgen deprivation therapy (ADT) using GnRH analogs, which suppress gonadal production of testosterone (T), and PCa cells at this stage are castration sensitive (Supplementary Fig. 1a). This evidence concerns the gene GNRH1 and posterior cortical atrophy.